A detailed history of Darwin Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Darwin Advisors, LLC holds 300 shares of MDT stock, worth $27,561. This represents 0.01% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$27,561
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$76.84 - $91.03 $23,052 - $27,309
300 New
300 $27,000
Q2 2020

Aug 06, 2020

SELL
$84.11 - $103.33 $76,035 - $93,410
-904 Closed
0 $0
Q1 2020

May 01, 2020

SELL
$72.92 - $121.3 $116,161 - $193,230
-1,593 Reduced 63.8%
904 $81,000
Q4 2019

Feb 14, 2020

BUY
$104.49 - $114.54 $25,495 - $27,947
244 Added 10.83%
2,497 $283,000
Q3 2019

Oct 16, 2019

SELL
$98.02 - $111.18 $47,539 - $53,922
-485 Reduced 17.71%
2,253 $245,000
Q2 2019

Aug 07, 2019

BUY
$84.15 - $99.38 $41,149 - $48,596
489 Added 21.74%
2,738 $267,000
Q1 2019

May 01, 2019

BUY
$82.45 - $93.79 $185,430 - $210,933
2,249 New
2,249 $205,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $122B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.